Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Infection
Published in: Infection 1/2014

01-02-2014 | Correspondence

Reactive haemophagocytic syndrome in a patient with adult-onset Still’s disease: beta-lactams as trigger?

Authors: F. Mearelli, P. Vinci, M. Gigli, C. Casarsa, G. Biolo

Published in: Infection | Issue 1/2014

Login to get access

Excerpt

Dear Editor, …
Literature
1.
Ohote R, Simon J, Papo T, Detournay B, Sailler L, Andre MH, Dupond JL, Larroche C, Piette AM, Mechenstock D, Ziza JM, Arlaud J, Labussiere AS, Desvaux A, Baty V, Blanche P, Schaeffer A, Piette JC, Guillevin L, Boissonnas A, Christoforov B. Reactive hemophagocytic syndrome in adult systemic disease: report of twenty-six cases and literature review. Arthritis Rheum. 2003;49:633–9.CrossRef
2.
Emmenegger U, Schaer DJ, Larroche C, Neftel KA. Hemophagocytic syndromes in adults: current concepts and challenges ahead. Swiss Med Wky. 2005;135:299–314.
3.
Fukaya S, Yasuda S, Hashimoto T, Oku K, Kataoka H, Horita T, Atsumi T, Koike T. Clinical features of hemophagocytic syndrome in patients with systemic autoimmune diseases: analysis of 30 cases. Rheumatology (Oxford). 2008;47:1686–91.CrossRef
4.
Gabilondo A, Ojeda E, Aranegi K, Goikoetxea U. Hemophagocytic lymphohistiocytosis associate with Epstein–Barr virus in an adult with Still disease. Med Clin (Barc). 2006;127:358–9.CrossRef
5.
Gianella S, Schaer DJ, Schwarz U, Kurrer M, Heppner FL, Fehr J, Seebach JD. Retinal microangiopathy and rapidly fatal cerebral edema in a patient with adult-onset Still’s disease and concurrent macrophage activation syndrome. Am J Hematol. 2008;83:424–7.PubMedCrossRef
6.
Hamidou M, Boutoille D, Masseau A, Garand R, Raffi F. Adult-onset Still disease with hemophagocytic syndrome treated with cyclosporine. Presse Med. 2005;34:1634–6.PubMedCrossRef
7.
Kumakura S, Ishikura H, Munemasa S, Adachi T, Murakawa Y, Kobayashi S. Adult onset Still’s disease associated hemophagocytosis. J Rheumatol. 1997;24:1645–8.PubMed
8.
Takeshita T, Takeuchi A, Nakagawa Y, Tsuda A, Fukuda K, Nariyama Y. Shibayama, Adult onset Still’s disease with hemophagocytic syndrome and severe liver dysfunction. Hepatol Res. 2000;17:139–44.PubMedCrossRef
9.
Motegi, Mizuno H, Arakawa H, et al. A case of hemophagocytic syndrome induced by penicillin G. Shonika Rinsho. 1996;49:2099–103.
Metadata
Title
Reactive haemophagocytic syndrome in a patient with adult-onset Still’s disease: beta-lactams as trigger?
Authors
F. Mearelli
P. Vinci
M. Gigli
C. Casarsa
G. Biolo
Publication date
01-02-2014
Publisher
Springer Berlin Heidelberg
Published in
Infection / Issue 1/2014
Print ISSN: 0300-8126
Electronic ISSN: 1439-0973
DOI
https://doi.org/10.1007/s15010-013-0548-2

Other articles of this Issue 1/2014

Infection 1/2014 Go to the issue

Clinical and Epidemiological Study

Comparison of colistin and colistin/sulbactam for the treatment of multidrug resistant Acinetobacter baumannii ventilator-associated pneumonia

Case Report

Chryseobacterium indologenes central nervous system infection in infancy: an emergent pathogen?

Correspondence

Antibiotic hospital consumption expressed in defined daily doses (DDD)/100 bed-days

Case Report

Peliosis hepatis due to disseminated tuberculosis in a patient with AIDS

Case Report

Brucella canis peritonitis

Correspondence

Community-acquired Klebsiella pneumoniae liver abscess: the London experience
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits